Year 2024 / Volume 116 / Number 3
Letter
Extensive involvement of indolent T-cell lymphoma in a patient with ulcerative colitis

165-166

DOI: 10.17235/reed.2023.9623/2023

Jiaoting Chen, Ning Su, Yan Huang, Min Zhang, Jiayin Yao, Guolin Li, Tenghui Ma, Min Zhi,

Abstract
Indolent T-cell lymphoma is a rare disease. Here we presented a 53-year-old male patient initially diagnosed as ulcerative colitis in 2000 that finally developed into extensive indolent T-cell lymphoma in 2022. We also described the differences between indolent T-cell lymphoma and inflammatory bowel disease, and the possible disease progression into lymphoma after biological therapy.
Share Button
New comment
Comments
No comments for this article
References
[1] Perry AM, Warnke RA, Hu Q, et al. Indolent T-cell lymphoproliferative disease of the gastrointestinal tract. Blood. 2013; 122: 3599-606.
[2] Sharma A, Oishi N, Boddicker RL, et al. Recurrent STAT3-JAK2 fusions in indolent T-cell lymphoproliferative disorder of the gastrointestinal tract. Blood. 2018; 131: 2262-66.
[3] Takahashi N, Tsukasaki K, Kohri M, et al. Indolent T-cell lymphoproliferative disorder of the stomach successfully treated by radiotherapy. J Clin Exp Hematop. 2020; 60: 7-10.
[4] Thomas SJ, Morley N, Lashen H, et al. Indolent T-Cell Lymphoproliferative Disorder of the Uterine Corpus: A Case Report., 2020; 503-06.
[5] Kotlyar DS, Osterman MT, Diamond RH, et al. A systematic review of factors that contribute to hepatosplenic T-cell lymphoma in patients with inflammatory bowel disease. Clin Gastroenterol Hepatol. 2011; 9: 36-41.
Related articles

Letter

Broadening perspectives in the treatment of chronic pouchitis

DOI: 10.17235/reed.2024.10865/2024

Letter

Tofacitinib-induced eosinophilia

DOI: 10.17235/reed.2023.9831/2023

Letter

Perianal Paget’s disease

DOI: 10.17235/reed.2022.9304/2022

Letter

Chinese dragon sign of ulcerative colitis

DOI: 10.17235/reed.2022.9154/2022

Letter

Ulcerative colitis exacerbated by strongyloidiasis

DOI: 10.17235/reed.2022.9044/2022

Review

Clinical settings with tofacitinib in ulcerative colitis

DOI: 10.17235/reed.2022.8660/2022

Letter

Mesalazine induced interstitial pneumonitis in the COVID era

DOI: 10.17235/reed.2022.8635/2021

Letter

The effect of Adacolumn® on ulcerative colitis with COVID-19

DOI: 10.17235/reed.2020.7156/2020

Letter

Sweet syndrome in severe ulcerative flare

DOI: 10.17235/reed.2020.6995/2020

Letter to the Editor

Ulcerative colitis with gastric and duodenal involvement

DOI: 10.17235/reed.2017.4685/2016

Editorial

Specialist care in the management of inflammatory bowel disease

DOI: 10.17235/reed.2016.4628/2016

Original

Mercaptopurine and inflammatory bowel disease: the other thiopurine

DOI: 10.17235/reed.2016.4546/2016

Case Report

Mesalamine-induced myopericarditis - A case report

DOI: 10.17235/reed.2016.4016/2015

Citation tools
Chen J, Su N, Huang Y, Zhang M, Yao J, Li G, et all. Extensive involvement of indolent T-cell lymphoma in a patient with ulcerative colitis. 9623/2023


Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Metrics
This article has received 1015 visits.
This article has been downloaded 32 times.

Statistics from Dimensions


Statistics from Plum Analytics

Publication history

Received: 25/03/2023

Accepted: 03/04/2023

Online First: 19/04/2023

Published: 04/03/2024

Article Online First time: 25 days

Article editing time: 345 days


Share
This article hasn't been rated yet.
Reader rating:
Valora este artículo:




Asociación Española de Ecografía Digestiva Sociedad Española de Endoscopia Digestiva Sociedad Española de Patología Digestiva
The Spanish Journal of Gastroenterology is the official organ of the Sociedad Española de Patología Digestiva, the Sociedad Española de Endoscopia Digestiva and the Asociación Española de Ecografía Digestiva
Cookie policy Privacy Policy Legal Notice © Copyright 2024 y Creative Commons. The Spanish Journal of Gastroenterology